These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

770 related items for PubMed ID: 9711451

  • 1. Azithromycin. A review of its use in paediatric infectious diseases.
    Langtry HD, Balfour JA.
    Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
    [Abstract] [Full Text] [Related]

  • 2. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.
    Dunn CJ, Barradell LB.
    Drugs; 1996 Mar; 51(3):483-505. PubMed ID: 8882383
    [Abstract] [Full Text] [Related]

  • 3. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM, Scott LJ.
    Drugs; 2004 Mar; 64(13):1433-64. PubMed ID: 15212560
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. History of macrolide use in pediatrics.
    Klein JO.
    Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154
    [Abstract] [Full Text] [Related]

  • 6. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
    Müller O.
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():137-46. PubMed ID: 8396085
    [Abstract] [Full Text] [Related]

  • 7. Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
    Langtry HD, Brogden RN.
    Drugs; 1997 Jun; 53(6):973-1004. PubMed ID: 9179528
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of azithromycin, amoxicillin/clavulanic acid and cefaclor in the treatment of acute ENT infections].
    García Callejo FJ, Velert Vila MM, Orts Alborch MH, Pardo Mateu L, Esparcia Navarro M.
    Acta Otorrinolaringol Esp; 1998 May; 49(4):306-12. PubMed ID: 9707742
    [Abstract] [Full Text] [Related]

  • 9. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B, Perry CM.
    Paediatr Drugs; 2001 May; 3(2):137-58. PubMed ID: 11269640
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacokinetic and clinical evaluation of azithromycin using fine granules or capsules in the pediatric patients].
    Toyonaga Y, Ishihara T, Nakamura H.
    Jpn J Antibiot; 1996 Nov; 49(11):981-93. PubMed ID: 8988410
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group.
    O'Doherty B.
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):718-24. PubMed ID: 8922571
    [Abstract] [Full Text] [Related]

  • 14. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.
    Easton J, Noble S, Perry CM.
    Drugs; 2003 Sep; 63(3):311-40. PubMed ID: 12534334
    [Abstract] [Full Text] [Related]

  • 15. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H, Liu YL, Chen MJ, Xu YC, Sun HL, Yang QW, Hu YJ, Cao B, Chu YZ, Liu Y, Zhang R, Yu YS, Sun ZY, Zhuo C, Ni YX, Hu BJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [Abstract] [Full Text] [Related]

  • 16. Azithromycin and clarithromycin: overview and comparison with erythromycin.
    Whitman MS, Tunkel AR.
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067
    [Abstract] [Full Text] [Related]

  • 17. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH.
    Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
    [Abstract] [Full Text] [Related]

  • 18. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH, Friedel HA, McTavish D.
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [Abstract] [Full Text] [Related]

  • 19. Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases.
    Treadway G, Reisman A.
    Int J Antimicrob Agents; 2001 Nov; 18(5):427-31. PubMed ID: 11711256
    [Abstract] [Full Text] [Related]

  • 20. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.
    Melo-Cristino J, Santos L, Ramirez M, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Rev Port Pneumol; 2006 Nov; 12(1):9-30. PubMed ID: 16572254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.